Literature DB >> 12077110

Thiopurine metabolites and the role of thiopurine methyltransferase activity in inflammatory bowel disease.

A Qasim, M Buckley, C A O' Morain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077110      PMCID: PMC1773292          DOI: 10.1136/gut.51.1.141

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  Rational dosing of azathioprine and 6-mercaptopurine.

Authors:  W J Sandborn
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease.

Authors:  P W Lowry; C L Franklin; A L Weaver; M G Pike; D C Mays; W J Tremaine; J J Lipsky; W J Sandborn
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 3.  The clinical pharmacology of 6-mercaptopurine.

Authors:  L Lennard
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.

Authors:  M C Dubinsky; S Lamothe; H Y Yang; S R Targan; D Sinnett; Y Théorêt; E G Seidman
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

5.  An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.

Authors:  M C Dubinsky; P V Hassard; E G Seidman; L Y Kam; M T Abreu; S R Targan; E A Vasiliauskas
Journal:  Inflamm Bowel Dis       Date:  2001-08       Impact factor: 5.325

6.  6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.

Authors:  C Cuffari; Y Théorêt; S Latour; G Seidman
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.